Medpace Holdings, Inc. (MEDP)
- Sector
- Life Sciences Tools & Services
- Last price
- $609.89
- As of
Kresmion compiles this page from MEDP's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Medpace Holdings, Inc. (MEDP): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-23.
See the full MEDP dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MEDP on one page. Preview it with sample data, then open it live with a free account.
Preview the MEDP dossierActive signals for MEDP
- highinsider_cluster_sell
4 insiders at MEDP sold $45.8M this week
- highinsider_cluster_sell
4 insiders at MEDP sold $35.9M this week
- mediumtrend_spike
Medpace Holdings, Inc. search volume spiked +100 pts, unusual interest
- highinsider_cluster_sell
3 insiders at MEDP sold $10.9M this week
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +136% to MEDP (2026Q2)
FREE, NO ACCOUNT
Every signal on MEDP, as it fires
You are seeing 5 of 16 signals recorded on MEDP since 2026-06-05.
The five above landed across 3 days. The other 11 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MEDP (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 58506Q109 · 2026Q2 | $220.1M | 0.30% | , |
| D. E. Shaw & Co., Inc.CUSIP 58506Q109 · 2026Q2 | $124.2M | 0.06% | , |
| Bridgewater Associates, LPCUSIP 58506Q109 · 2026Q2 | $8.3M | 0.03% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 58506Q109 · 2026Q2 | $5.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MEDP
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
MEDP against its peers
MEDP's operating margin of 21.1% ranks in the 90th percentile of 23 Life Sciences Tools & Services sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-06-30.
| Metric | MEDP | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.5B USD | 1.2B USD | 56 | 25 |
| Gross margin | n/a | 57.3% | n/a | 12 |
| Operating margin | 21.1% | -3.8% | 90 | 23 |
| Net margin | 17.8% | -3.6% | 83 | 25 |
| Return on equity | 98.3% | -5.0% | 98 | 24 |
| P / E | 39.9x | 44.5x | 38 | 11 |
| 1 year | 15.6% | 28.0% | 21 | 25 |
Peers (25): CRL, TEM, TECH, RGEN, AVTR, TXG, MTD, BRKR, ILMN, WAT, IQV, A, SHC, ADPT, ABCL, FTRE, DHR, TMO, MRVI, DNA, MLAB, CTKB, OABI, PACB, CDXS. Fiscal periods ending between 2025-10-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MEDP: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow MEDP on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to MEDP for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.